CRISPR Design tools

Publication Data

Publication Curation and Resources for Genome Editing
Genome-editing is a powerful technique that allows creating knock-in/out mutations in any gene and any cell. While curated genome-editing publications here are primarily focused on Crispr-Cas9 technologies, clinical trials, protocols and expression vectors cover a broader technologies including Crispr-Cas9, Zinc finger nuclease (ZFN) and Tale Nuclease (TALEN). In our publication curation, it includes species, genes, gRNA's, in publications
Publication Curation Summary
Species Group:
Clinical trials
 
Resources
DiseasePhaseTarget GeneInterventionStudy Details
Phase 1
PD-1
Biological: PD-1 Knockout T Cells/Drug: Cyclophosphamide/Drug: IL-2
Phase 1
CCR5
Drug: ZFN Modified CD4+ T Cells/Drug: Cyclophosphamide
Phase 1/Phase 2
PD-1
Drug: Fludarabine/Drug: Cyclophosphamide/Drug: Interleukin-2
Phase 1
PD-1
Drug: Cyclophosphamide/Other: PD-1 Knockout T Cells/Drug: Interleukin-2
Other: Blood sample for genetic purpose
Phase 1
CCR5
Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning
Phase 2
PD-1
Drug: Cyclophosphamide/Drug: Interleukin-2/Other: PD-1 Knockout T Cells
Phase 1
HPV16 E6/E7 and HPV18 E6/E7
Biological: TALEN/Biological: CRISPR/Cas9
Phase 1/Phase 2
CD19(UCART019)
Biological: UCART019
Phase 1/Phase 2
Genetic: SB-728-T/Genetic: SB-728-T/Genetic: SB-728-T/Genetic: SB-728-T/Genetic: SB-728-T
Phase 1
Drug: Plerixafor
Other: Exposure: abundance of Immature Myeloid Cells counts in blood samples; Other: Exposure: abundance of Immature Dentritic Cells counts in blood samples; Other: Exposure: abundance of Immature monocytes counts in blood samples; Other: Exposure: abundance of Immature neutrophils counts in blood samples
Phase 1
Iduronate 2-Sulfatase (IDS)
Biological: SB-913
Genetic: Organoid in vitro culture
Phase 1
PD-1
Biological: PD-1 Knockout T Cells/Drug: Cyclophosphamide/Drug: IL-2
Phase 1
Factor 9 gene
Biological: SB-FIX
Phase 1/Phase 2
CCR5
Genetic: SB-728mR-T/Genetic: SB-728mR-T/Drug: Cyclophosphamide
Phase 1
CCR5
Genetic: SB-728-T
Filters
Type of diseases
Type of editing tools
Protocol TitlePublication TimeDownloadMore
2017
2017
2017
2017
2017
2017
Filters
Protocols
Sources
Field
NameSpeciesGene EditingPromoterSelection MarkerMore
NA
NA
hPGK, hU6(-250)
AMPr
NA
NA
PGK, AmpR, T3, U6, T7
AmpR
NA
NA
T3, T7
ampR
NA
NA
hPGK, U6, HuEF1alphapromoter
PuroR, BetaLactamase(AmpR)
Homo sapiens
NA
NA
NA
NA
NA
CMVprmt
KanR
NA
NA
EF-1alpha
ampicillinresistance
NA
NA
T3, U6, T7, UbC
ampR
NA
NA
hPGK, InducibleU6
AMPr
NA
NA
T3, T7, CMVprmt
ampR
NA
NA
T3, T7, PGK
ampR
NA
NA
CMV
AmpR
NA
NA
hPGK,CMV
PuroR, BetaLactamase(AmpR)
NA
NA
CMVprmt
KanR
NA
NA
hPGK,CMV
PuroR, BetaLactamase(AmpR)
NA
NA
T3, CMV, T7
KanR
NA
NA
NA
KanR
NA
NA
T3, T7, Ef1-a
ampR
NA
NA
CMV
AmpR
NA
NA
hPGK,CMV
PuroR, BetaLactamase(AmpR)
Filters
Type of gene editing

CRISPR Genome-Editing

Welcome to the CRISPR-Cas9 Genome-Editing Discussion Forum!

Sample Discussion

Sample comment

by: crispr@mailinator.com Feb 13, 2020 10:00 AM Comment(s) 0

Publication

Test details for publication data

by: Guest Oct 9, 2019 03:10 PM Comment(s) 0

dfdfdsf

sdfsdfdf

by: christopher.wilke@merckgroup.com Jul 24, 2019 01:20 PM Comment(s) 0

test

test2

by: christopher.wilke@merckgroup.com Jul 24, 2019 01:03 PM Comment(s) 0

test

test

by: christopher.wilke@merckgroup.com Jul 24, 2019 01:02 PM Comment(s) 0

test

</textarea>test

by: Guest Jul 23, 2019 11:53 AM Comment(s) 0

this is for education

if you want any queries related to education.please click below link

by: vuppala.leelakrishna@merckgroup.com Jul 18, 2019 03:07 PM Comment(s) 0

Blog

this is protocols

by: vuppala.leelakrishna@merckgroup.com Jul 18, 2019 03:03 PM Comment(s) 0

abb

hi this is hac

by: vuppala.leelakrishna@merckgroup.com Jul 18, 2019 03:01 PM Comment(s) 0

Hacker

Hacking

by: Guest Jul 17, 2019 01:02 PM Comment(s) 0
Filters
Category